West Coast Financial LLC lowered its stake in Cerner Co. (NASDAQ:CERN) by 0.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 132,017 shares of the company’s stock after selling 539 shares during the period. Cerner accounts for approximately 2.5% of West Coast Financial LLC’s investment portfolio, making the stock its 5th largest position. West Coast Financial LLC’s holdings in Cerner were worth $7,769,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of the company. Morgan Stanley raised its stake in Cerner by 151.6% in the third quarter. Morgan Stanley now owns 1,219,077 shares of the company’s stock valued at $75,278,000 after buying an additional 734,622 shares in the last quarter. Stephens Investment Management Group LLC raised its stake in Cerner by 15.0% in the third quarter. Stephens Investment Management Group LLC now owns 394,239 shares of the company’s stock valued at $24,344,000 after buying an additional 51,274 shares in the last quarter. World Asset Management Inc raised its stake in Cerner by 2.1% in the third quarter. World Asset Management Inc now owns 29,704 shares of the company’s stock valued at $1,834,000 after buying an additional 617 shares in the last quarter. Sumitomo Mitsui Asset Management Company LTD raised its stake in Cerner by 1,079.4% in the third quarter. Sumitomo Mitsui Asset Management Company LTD now owns 282,408 shares of the company’s stock valued at $17,438,000 after buying an additional 258,463 shares in the last quarter. Finally, Northern Trust Corp raised its stake in Cerner by 0.5% in the third quarter. Northern Trust Corp now owns 3,931,748 shares of the company’s stock valued at $242,786,000 after buying an additional 18,011 shares in the last quarter. Institutional investors and hedge funds own 80.58% of the company’s stock.

Institutional Ownership by Quarter for Cerner (NASDAQ:CERN)

Shares of Cerner Co. (NASDAQ:CERN) traded down 0.96% during trading on Friday, hitting $58.78. 787,932 shares of the stock were exchanged. The firm has a market capitalization of $19.38 billion, a price-to-earnings ratio of 31.77 and a beta of 1.05. Cerner Co. has a 52 week low of $47.01 and a 52 week high of $67.50. The stock’s 50 day moving average price is $57.50 and its 200 day moving average price is $54.08.



Cerner (NASDAQ:CERN) last issued its quarterly earnings data on Thursday, February 9th. The company reported $0.61 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.61. Cerner had a net margin of 13.27% and a return on equity of 18.16%. The business earned $1.26 billion during the quarter, compared to analyst estimates of $1.26 billion. During the same period in the prior year, the business earned $0.61 EPS. The company’s revenue for the quarter was up 7.0% on a year-over-year basis. On average, equities analysts predict that Cerner Co. will post $2.50 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: This story was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another domain, it was illegally copied and republished in violation of United States & international trademark and copyright legislation. The correct version of this story can be accessed at https://www.thecerbatgem.com/2017/04/21/west-coast-financial-llc-sells-539-shares-of-cerner-co-cern.html.

CERN has been the topic of several analyst reports. Canaccord Genuity reiterated a “buy” rating and set a $63.00 price target on shares of Cerner in a research report on Friday, January 13th. Jefferies Group LLC reiterated a “buy” rating and set a $63.00 price target on shares of Cerner in a research report on Tuesday, February 14th. Deutsche Bank AG lowered shares of Cerner from a “buy” rating to a “hold” rating in a research report on Tuesday, January 31st. Cantor Fitzgerald reiterated an “overweight” rating and set a $66.00 price target on shares of Cerner in a research report on Wednesday, February 22nd. Finally, Citigroup Inc lowered shares of Cerner from a “buy” rating to a “neutral” rating in a research report on Friday, February 24th. They noted that the move was a valuation call. Two analysts have rated the stock with a sell rating, thirteen have given a hold rating and ten have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $62.15.

In other Cerner news, Chairman Neal L. Patterson sold 20,000 shares of the company’s stock in a transaction on Tuesday, March 14th. The shares were sold at an average price of $54.91, for a total value of $1,098,200.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Jeffrey A. Townsend sold 100,000 shares of the company’s stock in a transaction on Monday, February 13th. The stock was sold at an average price of $52.31, for a total transaction of $5,231,000.00. The disclosure for this sale can be found here. 13.20% of the stock is currently owned by corporate insiders.

About Cerner

Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.

5 Day Chart for NASDAQ:CERN

Receive News & Stock Ratings for Cerner Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner Co. and related stocks with our FREE daily email newsletter.